Pulsenmore Secures $7.5M Private Placement, Shares Priced at $4.80
PLSM sits 88% above its 52-week low of $3 on elevated volume (62× avg).
Summary
Pulsenmore announced a $7.5 million private placement with a single healthcare-focused institutional investor. The offering includes 1,562,500 ordinary shares (or pre-funded warrants) and warrants to purchase an equal number of shares, priced at $4.80 per share and accompanying warrant. This capital raise, representing approximately 17.5% of the company's market cap, is intended to fund commercial expansion, particularly in the U.S. market, and other strategic growth initiatives. The offering price of $4.80 is below the current market price of $5.65, indicating dilution for existing shareholders. This financing follows the recent strategic partnership with Ouma Health and FDA approval for its ES device, supporting the company's growth trajectory.
At the time of this announcement, PLSM was trading at $5.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $42.9M. The 52-week trading range was $3.00 to $12.97. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.